Immunogenicity of a novel enhanced consensus DNA vaccine encoding the leptospiral protein LipL45

References

• Levett PN. Systematics of leptospiraceae. Curr Top Microbiol Immunol 2015; 387:11-20; PMID:25388130
   PubMed Web of Science ®Google Scholar
• Gouveia EL, Metcalfe J, de Carvalho AL, Aires TS, Villasboas-Bisneto JC, Queirroz A, Santos AC, Salgado K, Reis MG, Ko AI. Leptospirosis-associated severe pulmonary hemorrhagic syndrome, Salvador, Brazil. Emerg Infect Dis 2008; 14:505-8; PMID:18325275; http://dx.doi.org/10.3201/eid1403.071064
   PubMed Web of Science ®Google Scholar
• Terpstra WJ. Human leptospirosis: guidance for diagnosis, surveillance and control. Geneva: WHO/ILS, WHO library; 2003:109.
   Google Scholar
• Meites E, Jay MT, Deresinski S, Shieh W-J, Zaki SR, Tompkins L, Smith DS. Reemerging Leptospirosis, California. Emerg Infect Dis 2004; 10:406-12; PMID:15109405; http://dx.doi.org/10.3201/eid1003.030431
   PubMed Web of Science ®Google Scholar
• Vijayachari P, Sugunan A, Shriram A. Leptospirosis: an emerging global public health problem. J biosci 2008; 33:557-69; PMID:19208981; http://dx.doi.org/10.1007/s12038-008-0074-z
   PubMed Web of Science ®Google Scholar
• Pappas G, Papadimitriou P, Siozopoulou V, Christou L, Akritidis N. The globalization of leptospirosis: worldwide incidence trends. Int J Infect Dis 2008; 12:351-7; PMID:18055245; http://dx.doi.org/10.1016/j.ijid.2007.09.011
   PubMed Web of Science ®Google Scholar
• Cerqueira G, Picardeau M. A century of Leptospira strain typing. Infect Genet Evol 2009; 9:760-8; PMID:19540362; http://dx.doi.org/10.1016/j.meegid.2009.06.009
   PubMed Web of Science ®Google Scholar
• Barocchi MA, Ko AI, Reis MG, McDonald KL, Riley LW. Rapid translocation of polarized MDCK cell monolayers by Leptospira interrogans, an invasive but nonintracellular pathogen. Infect Immun 2002; 70:6926-32; PMID:12438371; http://dx.doi.org/10.1128/IAI.70.12.6926-6932.2002
   PubMed Web of Science ®Google Scholar
• Merien F, Baranton G, Perolat P. Invasion of Vero cells and induction of apoptosis in macrophages by pathogenic Leptospira interrogans are correlated with virulence. Infect Immun 1997; 65:729-38; PMID:9009336
   PubMed Web of Science ®Google Scholar
• Sonrier C, Branger C, Michel V, Ruvoen-Clouet N, Ganiere JP, Andre-Fontaine G. Evidence of cross-protection within Leptospira interrogans in an experimental model. Vaccine 2000; 19:86-94; PMID:10924790; http://dx.doi.org/10.1016/S0264-410X(00)00129-8
   PubMed Web of Science ®Google Scholar
• Wang Z, Jin L, Wegrzyn A. Leptospirosis vaccines. Microb Cell Fact 2007; 6:39; PMID:18072968; http://dx.doi.org/10.1186/1475-2859-6-39
   PubMed Web of Science ®Google Scholar
• Maneewatch S, Tapchaisri P, Sakolvaree Y, Klaysing B, Tongtawe P, Chaisri U, Songserm T, Wongratanacheewin S, Srimanote P, Chongsa-nguanz M, et al. OmpL1 DNA vaccine cross-protects against heterologous Leptospira spp. challenge. Asian Pac J Allergy Immunol 2007; 25:75-82; PMID:17891923
   PubMed Web of Science ®Google Scholar
• Ferraro B, Morrow MP, Hutnick NA, Shin TH, Lucke CE, Weiner DB. Clinical applications of DNA vaccines: current progress. Clin Infect Dis 2011; 53:296-302; PMID:21765081; http://dx.doi.org/10.1093/cid/cir334
   PubMed Web of Science ®Google Scholar
• Kutzler MA, Weiner DB. DNA vaccines: ready for prime time? Nat Rev Genet 2008; 9:776-88; PMID:18781156; http://dx.doi.org/10.1038/nrg2432
   PubMed Web of Science ®Google Scholar
• Gurunathan S, Klinman DM, Seder RA. DNA vaccines: immunology, application, and optimization. Annu Rev Immunol 2000; 18:927-74; PMID:10837079; http://dx.doi.org/10.1146/annurev.immunol.18.1.927
   PubMed Web of Science ®Google Scholar
• Ido Y, Hoki R, Ito H, Wani H. The prophylaxis of Weil's disease (spirochaetosis Icterohaemorrhagica). J Exp Med 1916; 24:471-83; PMID:19868055; http://dx.doi.org/10.1084/jem.24.5.471
   PubMedGoogle Scholar
• Adler B, de la Pena Moctezuma A. Leptospira and leptospirosis. Vet Microbiol 2010; 140:287-96; PMID:19345023; http://dx.doi.org/10.1016/j.vetmic.2009.03.012
   PubMed Web of Science ®Google Scholar
• Naiman BM, Alt D, Bolin CA, Zuerner R, Baldwin CL. Protective killed Leptospira borgpetersenii vaccine induces potent Th1 immunity comprising responses by CD4 and gammadelta T lymphocytes. Infect Immun 2001; 69:7550-8; PMID:11705932; http://dx.doi.org/10.1128/IAI.69.12.7550-7558.2001
   PubMed Web of Science ®Google Scholar
• Adler B. Vaccines against leptospirosis. Curr Top Microbiol Immunol 2015; 387:251-72; PMID:25388138
   PubMed Web of Science ®Google Scholar
• Dong H, Hu Y, Xue F, Sun D, Ojcius DM, Mao Y, Yan J. Characterization of the ompL1 gene of pathogenic Leptospira species in China and cross-immunogenicity of the OmpL1 protein. BMC Microbiol 2008; 8:223; PMID:19087358; http://dx.doi.org/10.1186/1471-2180-8-223
   PubMed Web of Science ®Google Scholar
• Cullen PA, Xu X, Matsunaga J, Sanchez Y, Ko AI, Haake DA, Adler B. Surfaceome of Leptospira spp. Infect Immun 2005; 73:4853-63; PMID:16040999; http://dx.doi.org/10.1128/IAI.73.8.4853-4863.2005
   PubMed Web of Science ®Google Scholar
• Haake DA, Chao G, Zuerner RL, Barnett JK, Barnett D, Mazel M, Matsunaga J, Levett PN, Bolin CA. The leptospiral major outer membrane protein LipL32 is a lipoprotein expressed during mammalian infection. Infect Immun 2000; 68:2276-85; PMID:10722630; http://dx.doi.org/10.1128/IAI.68.4.2276-2285.2000
   PubMed Web of Science ®Google Scholar
• Murray GL. The lipoprotein LipL32, an enigma of leptospiral biology. Vet Microbiol 2013; 162:305-14; PMID:23206414; http://dx.doi.org/10.1016/j.vetmic.2012.11.005
   PubMed Web of Science ®Google Scholar
• Maneewatch S, Sakolvaree Y, Saengjaruk P, Srimanote P, Tapchaisri P, Tongtawe P, Klaysing B, Wongratanacheewin S, Chongsa-Nguan M, Chaicumpa W. Monoclonal antibodies to LipL32 protect against heterologous Leptospira spp. challenge. Hybridoma (Larchmt) 2008; 27:453-65; PMID:19108618; http://dx.doi.org/10.1089/hyb.2008.0056
   PubMed Web of Science ®Google Scholar
• Guerreiro H, Croda J, Flannery B, Mazel M, Matsunaga J, Galvao Reis M, Levett PN, Ko AI, Haake DA. Leptospiral proteins recognized during the humoral immune response to leptospirosis in humans. Infect Immun 2001; 69:4958-68; PMID:11447174; http://dx.doi.org/10.1128/IAI.69.8.4958-4968.2001
   PubMed Web of Science ®Google Scholar
• Branger C, Sonrier C, Chatrenet B, Klonjkowski B, Ruvoen-Clouet N, Aubert A, André-Fontaine G, Eloit M. Identification of the hemolysis-associated protein 1 as a cross-protective immunogen of Leptospira interrogans by adenovirus-mediated vaccination. Infect Immun 2001; 69:6831-8; PMID:11598056; http://dx.doi.org/10.1128/IAI.69.11.6831-6838.2001
   PubMed Web of Science ®Google Scholar
• Luo D, Xue F, Ojcius DM, Zhao J, Mao Y, Li L, Lin X, Yan J. Protein typing of major outer membrane lipoproteins from Chinese pathogenic Leptospira spp. and characterization of their immunogenicity. Vaccine 2009; 28:243-55; PMID:19796723; http://dx.doi.org/10.1016/j.vaccine.2009.09.089
   PubMed Web of Science ®Google Scholar
• Grassmann AA, Felix SR, dos Santos CX, Amaral MG, Seixas Neto AC, Fagundes MQ, Seixas FK, da Silva EF, Conceição FR, Dellagostin OA. Protection against lethal leptospirosis after vaccination with LipL32 coupled or coadministered with the B subunit of Escherichia coli heat-labile enterotoxin. Clin Vaccine Immunol 2012; 19:740-5; PMID:22379066; http://dx.doi.org/10.1128/CVI.05720-11
   PubMed Web of Science ®Google Scholar
• Branger C, Chatrenet B, Gauvrit A, Aviat F, Aubert A, Bach JM, André-Fontaine G. Protection against Leptospira interrogans sensu lato challenge by DNA immunization with the gene encoding hemolysin-associated protein 1. Infect Immun 2005; 73:4062-9; PMID:15972494; http://dx.doi.org/10.1128/IAI.73.7.4062-4069.2005
   PubMed Web of Science ®Google Scholar
• Umthong S, Buaklin A, Jacquet A, Sangjun N, Kerdkaew R, Patarakul K, Palaga T. Immunogenicity of a DNA and Recombinant Protein Vaccine Combining LipL32 and Loa22 for Leptospirosis Using Chitosan as a Delivery System. J Microbiol Biotechnol 2015; 25:526-36; PMID:25348693
   PubMed Web of Science ®Google Scholar
• Matsunaga J, Young TA, Barnett JK, Barnett D, Bolin CA, Haake DA. Novel 45-kilodalton leptospiral protein that is processed to a 31-kilodalton growth-phase-regulated peripheral membrane protein. Infect Immun 2002; 70:323-34; PMID:11748198; http://dx.doi.org/10.1128/IAI.70.1.323-334.2002
   PubMed Web of Science ®Google Scholar
• Muthumani K, Wise MC, Broderick KE, Hutnick N, Goodman J, Flingai S, Yan J, Bian CB, Mendoza J, Tingey C, Wilson C, et al. HIV-1 Env DNA Vaccine plus Protein Boost Delivered by EP Expands B- and T-Cell Responses and Neutralizing Phenotype In Vivo. PLoS One 2013; 8:e84234; PMID:24391921; http://dx.doi.org/10.1371/journal.pone.0084234
   PubMedGoogle Scholar
• Yang JS, Kim JJ, Hwang D, Choo AY, Dang K, Maguire H, Kudchodkar S, Ramanathan MP, Weiner DB. Induction of potent Th1-type immune responses from a novel DNA vaccine for West Nile virus New York isolate (WNV-NY1999). J Infect Dis 2001; 184:809-16; PMID:11550123; http://dx.doi.org/10.1086/323395
   PubMed Web of Science ®Google Scholar
• Kowalczyk DW, Ertl HC. Immune responses to DNA vaccines. Cell Mol Life Sci 1999; 55:751-70; PMID:10379361; http://dx.doi.org/10.1007/s000180050330
   PubMed Web of Science ®Google Scholar
• Hokey DA, Weiner DB. DNA vaccines for HIV: challenges and opportunities. Springer Semin Immunopathol 2006; 28:267-79.
   PubMed Web of Science ®Google Scholar
• Hutnick NA, Myles DJ, Bian CB, Muthumani K, Weiner DB. Selected approaches for increasing HIV DNA vaccine immunogenicity in vivo. Curr Opin Virol 2011; 1:233-40; PMID:22440782; http://dx.doi.org/10.1016/j.coviro.2011.08.003
   PubMed Web of Science ®Google Scholar
• Muthumani K, Wise MC, Broderick KE, Hutnick N, Goodman J, Flingai S, Yan J, Bian CB, Mendoza J, Tingey C, et al. HIV-1 Env DNA vaccine plus protein boost delivered by EP expands B and T-cell responses and neutralizing phenotype in vivo. PloS One 2013; 8:e84234; PMID:24391921; http://dx.doi.org/10.1371/journal.pone.0084234
   PubMedGoogle Scholar
• Mallilankaraman K, Shedlock DJ, Bao H, Kawalekar OU, Fagone P, Ramanathan AA, Ferraro B, Stabenow J, Vijayachari P, Sundaram SG, et al. A DNA vaccine against chikungunya virus is protective in mice and induces neutralizing antibodies in mice and nonhuman primates. PLoS Negl Trop Dis 2011; 5:e928; PMID:21264351; http://dx.doi.org/10.1371/journal.pntd.0000928
   PubMed Web of Science ®Google Scholar
• Villarreal DO, Talbott KT, Choo DK, Shedlock DJ, Weiner DB. Synthetic DNA vaccine strategies against persistent viral infections. Expert Rev Vaccines 2013; 12:537-54; PMID:23659301; http://dx.doi.org/10.1586/erv.13.33
   PubMed Web of Science ®Google Scholar
• Bagarazzi ML, Yan J, Morrow MP, Shen X, Parker RL, Lee JC, Giffear M, Pankhong P, Khan AS, Broderick KE, et al. Immunotherapy against HPV16/18 generates potent TH1 and cytotoxic cellular immune responses. Sci Transl Med 2012; 4:155ra38; PMID:23052295; http://dx.doi.org/10.1126/scitranslmed.3004414
   PubMed Web of Science ®Google Scholar
• Shedlock DJ, Aviles J, Talbott KT, Wong G, Wu SJ, Villarreal DO, Myles DJ, Croyle MA, Yan J, Kobinger GP, et al. Induction of broad cytotoxic T cells by protective DNA vaccination against Marburg and Ebola. Mol Ther 2013; 21:1432-44; PMID:23670573; http://dx.doi.org/10.1038/mt.2013.61
   PubMed Web of Science ®Google Scholar
• Kalams SA, Parker S, Jin X, Elizaga M, Metch B, Wang M, Hural J, Lubeck M, Eldridge J, Cardinali M, et al. Safety and immunogenicity of an HIV-1 gag DNA vaccine with or without IL-12 and/or IL-15 plasmid cytokine adjuvant in healthy, HIV-1 uninfected adults. PLoS One 2012; 7:e29231; PMID:22242162; http://dx.doi.org/10.1371/journal.pone.0029231
   PubMed Web of Science ®Google Scholar
• Faisal SM, Yan W, Chen CS, Palaniappan RU, McDonough SP, Chang YF. Evaluation of protective immunity of Leptospira immunoglobulin like protein A (LigA) DNA vaccine against challenge in hamsters. Vaccine 2008; 26:277-87; PMID:18055070; http://dx.doi.org/10.1016/j.vaccine.2007.10.029
   PubMed Web of Science ®Google Scholar
• Muthumani K, Lankaraman KM, Laddy DJ, Sundaram SG, Chung CW, Sako E, Wu L, Khan A, Sardesai N, Kim JJ, et al. Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus. Vaccine 2008; 26:5128-34; PMID:18471943; http://dx.doi.org/10.1016/j.vaccine.2008.03.060
   PubMed Web of Science ®Google Scholar
• Babiuk LA, Babiuk SL, Loehr BI, van Drunnen Littel-van den H. Nucleic acid vaccines: research tool or commercial reality. Vet Immunol Immunopathol 2000; 76:1-23; PMID:10973683; http://dx.doi.org/10.1016/S0165-2427(00)00198-7
   PubMed Web of Science ®Google Scholar
• Forde GM. Rapid response vaccines does DNA offer a solution? Nat Biotechnol 2005; 23:1059-62; PMID:16151391; http://dx.doi.org/10.1038/nbt0905-1059
   PubMed Web of Science ®Google Scholar
• Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, et al. Direct gene transfer into mouse muscle in vivo. Science 1990; 247:1465-68; PMID:1690918; http://dx.doi.org/10.1126/science.1690918
   PubMed Web of Science ®Google Scholar
• Boyer JD, Robinson TM, Kutzler MA, Vansant G, Hokey DA, Kumar S, Felgner PL. Protection against simian/human immunodeficiency virus (SHIV) 89.6P in macaques after coimmunization with SHIV antigen and IL-15 plasmid. Proc Natl Acad Sci U S A 2007; 104:18648-53; PMID:18000037; http://dx.doi.org/10.1073/pnas.0709198104
   PubMed Web of Science ®Google Scholar
• Feng GH, Liu N, Zhou Y, Zhai YZ, Li XM, Dou XG. Immunologic analysis induced by DNA vaccine encoding E protein of Beijing-1 strain derived from Japanese encephalitis virus. Intervirology 2007; 50:93-8; PMID:17139185; http://dx.doi.org/10.1159/000097395
   PubMed Web of Science ®Google Scholar
• Laddy DJ, Yan J, Khan AS, Andersen H, Cohn A. Electroporation of synthetic DNA antigens offers protection in nonhuman primates challenged with highly pathogenic avian influenza virus. J Virol 2009; 83:4624-30; PMID:19211745; http://dx.doi.org/10.1128/JVI.02335-08
   PubMed Web of Science ®Google Scholar
• Kumar S, Yan J, Muthumani K, Ramanathan MP, Yoon H, Pavlakis GN, Felber BK, Sidhu M, Boyer JD, Weiner DB. Immunogenicity testing of a novel engineered HIV-1 envelope gp140 DNA vaccine construct. DNA Cell Biol 2006; 25:383-92; PMID:16848679; http://dx.doi.org/10.1089/dna.2006.25.383
   PubMed Web of Science ®Google Scholar
• Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S. The pro and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta 2011; 1813:878-88; PMID:21296109; http://dx.doi.org/10.1016/j.bbamcr.2011.01.034
   PubMed Web of Science ®Google Scholar
• Matsunaga J, Barocchi MA, Croda J, Young TA, Sanchez Y, Siqueira I, Bolin CA, Reis MG, Riley LW, Haake DA, et al. Pathogenic Leptospira species express surface-exposed proteins belonging to the bacterial immunoglobulin superfamily. Mol Microbiol 2003; 49:929-45; PMID:12890019; http://dx.doi.org/10.1046/j.1365-2958.2003.03619.x
   PubMed Web of Science ®Google Scholar
• Muthumani K, Flingai S, Wise M, Tingey C, Ugen KE, Weiner DB. Optimized and enhanced DNA plasmid vector based in vivo construction of a neutralizing anti-HIV-1 envelope glycoprotein Fab. Hum Vaccin Immunother 2013; 9:2253-62; PMID:24045230; http://dx.doi.org/10.4161/hv.26498
   PubMed Web of Science ®Google Scholar
• Garmory HS, Brown KA, Titball RW. DNA vaccines: improving expression of antigens. Genet Vaccines Ther 2003; 1:2; PMID:14606963; http://dx.doi.org/10.1186/1479-0556-1-2
   PubMedGoogle Scholar
• Kozak M. At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells. J Mol Biol 1987; 196:947-50; PMID:3681984; http://dx.doi.org/10.1016/0022-2836(87)90418-9
   PubMed Web of Science ®Google Scholar
• Bodles-Brakhop AM, Draghia-Akli R. DNA vaccination and gene therapy: optimization and delivery for cancer therapy. Expert Rev Vaccines 2008; 7:1085-101; PMID:18767956; http://dx.doi.org/10.1586/14760584.7.7.1085
   PubMed Web of Science ®Google Scholar
• Hirao LA, Wu L, Khan AS, Hokey DA, Yan J, Dai A, Betts MR, Draghia-Akli R, Weiner DB. Combined effects of IL-12 and electroporation enhances the potency of DNA vaccination in macaques. Vaccine 2008; 26:3112-20; PMID:18430495; http://dx.doi.org/10.1016/j.vaccine.2008.02.036
   PubMed Web of Science ®Google Scholar
• Boyer JD, Robinson TM, Kutzler MA, Vansant G, Hokey DA, Kumar S, Parkinson R, Wu L, Sidhu MK, Pavlakis GN, et al. Protection against simian/human immunodeficiency virus (SHIV) 89.6P in macaques after coimmunization with SHIV antigen and IL-15 plasmid. Proc Nat Acad Sci U S A 2007; 104:18648-53; PMID:18000037; http://dx.doi.org/10.1073/pnas.0709198104
   PubMed Web of Science ®Google Scholar
• Vedhagiri K, Velineni S, Timoney JF, Shanmughapriya S, Vijayachari P, Narayanan R, Natarajaseenivasan K. Detection of LipL32-specific IgM by ELISA in sera of patients with a clinical diagnosis of leptospirosis. Pathog Glob Health 2013; 107:130-5; PMID:23683367; http://dx.doi.org/10.1179/2047773213Y.0000000088
   PubMed Web of Science ®Google Scholar
• Heuzenroeder MW, Barton MD, Vanniasinkam T, Phumoonna T. Linear B-cell epitope mapping using enzyme-linked immunosorbent assay for libraries of overlapping synthetic peptides. Methods Mol Biol 2009; 524:137-44; PMID:19377942; http://dx.doi.org/10.1007/978-1-59745-450-6_10
   PubMedGoogle Scholar